Biotechnology Stocks II Performance Guide: Inozyme Pharma, Inc. (INZY)
INZY has no dividends.
Table and Chart of INZY Performance
See what a $1,000 investment in INZY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| INZY Returns | |
|---|---|
| Start Date | Aug-31-2020 |
| Start Price | $29.98 |
| End Date | May-16-2024 |
| End Price | $4.73 |
| # Prices | 46 |
| Min Date | Dec-30-2022 |
| Min Price | $1.05 |
| Max Date | Aug-31-2020 |
| Max Price | $29.98 |
| Total Return | -84.22% |
| Annualized Return | -38.23% |
| Current Value of $1,000 Purchase | $158 |
| Number Returns | 1,035 |
| Average Return | -22.23% |
| Number Profitable Returns | 232 |
| Percent Profitable Returns | 22.42% |
| Number Unprofitable Returns | 803 |
| Percent Unprofitable Returns | 77.58% |
| Profitable to Unprofitable Returns Ratio | 0.29 |
| INZY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $288,865,000 |
| Beta | 1.537 | Price to Sales |
| Earnings per Share | $-1.3500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.26 |
| PRICE DATA | |
| 52 Week High | $7.79 |
| 52 Week Low | $2.689 |
| Analyst Target Price | $20.33 |
| 50-Day Moving Average | $5.42 |
| 200-Day Moving Average | $4.642 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -69.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
INZY Compare Returns with S&P 500
INZY Trendline Chart
INZY Moving Average Chart
INZY Stock Return Map - See Patterns of Gains and Losses
INZY Stock Returns/Purchase Dates